Randomized Phase II Trial Followed by Phase III Trial With Molecular Biology Study, Comparing a Standard Bi-therapy vs 3 Arms of Intensified Chemotherapy in Patients With Unresectable or Not Optimally Resectable Colorectal Cancer Liver Metastases.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Response
end of chemotherapy
No
Marc YCHOU, MD, PhD
Principal Investigator
CRLC Val d'Aurelle
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
METHEP/2004/22
NCT00208260
April 2004
August 2007
Name | Location |
---|